Clinical Trial Update: A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV [Phase 2]

View source ↗

Summary

Phase 2 trial of IDN-6556 in post-orthotopic liver transplant patients with chronic hepatitis C-related liver disease has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Cirrhosis
• Hepatic Fibrosis
• Liver Cirrhosis
• Liver Fibrosis

Drugs mentioned

• IDN-6556

Snippet

Sponsor: Conatus Pharmaceuticals Inc. | Conditions: Liver Fibrosis, Hepatic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2019-12-11